This risk appears elevated with worse glycemic control. The exact mechanism for this increased risk is unknown but there are several proposed causes. Vitamin E has shown to reduce cardiovascular events in patients with both diabetes and the 2-2 genotype but the safety of implementing such therapy remains unknown. |